Citeline

Curious to learn more about our latest innovations propelling the future of pharma? Join us at SCOPE 2025 between February 3-6 in Orlando, Florida: https://ow.ly/mIes50UIAAN. Our friendly team will be available throughout the week and would love to chat with you about how Citeline can provide actionable insights for better trial execution, achieving diversity goals and identifying the right patients. _____ Follow Citeline Clinical, your unparalleled source of life science R&D intelligence on the market

According to Citeline data referenced in a recent article in The Economist: https://ow.ly/B5SE50Uq37v — Novo Nordisk and Eli Lilly & Company are expected to dominate the weight-loss drug market, while over 300 drugs are in the pipeline. (subscription required) _____ Follow Citeline, the leading provider of drug, device, company, clinical trial and market intelligence in the pharmaceutical and medtech markets. #ObesityDrugs #GLP1 #Wegovy #Zepbound

#SCOPE2025 is right around the corner! In the new era of Citeline, we're providing more insights than ever, helping you get to the answers faster and make informed decisions with confidence. Visit us at Booth 608 for your chance to win a great prize!

Don't miss us at #SCOPE2025 — come visit us at Booth 608!

Discover AI-driven solutions for ensuring regulatory compliance: https://ow.ly/aU2i50UqURh. With over 130 new regulatory updates published in the past year alone, the clinical trial disclosure landscape is more complex than ever. Discover how AI is revolutionizing this process—simplifying workflows, safeguarding sensitive data and ensuring compliance in an increasingly demanding environment. _____ Follow Citeline Regulatory, giving you the information, tools and services needed to maintain clinical trial disclosure compliance, mitigate risk, and increase transparency.

Citeline’s post #JPM2025 webinar is almost here! Register today to join us on Feb 5 at 10a ET/3p GMT: https://ow.ly/NYIj50UOKKB Sign up today to join Citeline’s expert panel of reporters and analysts as they unpack this year’s biggest deals, trends, and innovations and find out what these developments mean for you and the future of the industry in 2025 and beyond.

News is everywhere. But can you trust it? What can you learn from it? How can you leverage it to gain a competitive edge? Stop wondering. Start your free trial: https://ow.ly/lHgY50UqUUC and experience Citeline News & Insights like never before. Unlock world-class journalism and analysis of the pharma, biotech, medtech, and consumer health industries with 1-week’s access to our award-winning publications—Pink Sheet, Scrip, In Vivo, Medtech Insight, Generics Bulletin, and HBW Insight. _____ Follow Citeline Commercial for your comprehensive industry news and strategic insights into the global life sciences and biotechnology markets. #Pharma #BioPharma #PharmaNews

We on Citeline's Scrip have been asking leaders and experts from across the #biopharma/health spectrum about what they expect from #AI and data science in the coming year. With more than 50 perspectives over topics ranging from target identification and drug discovery to HCP decision-making, personalized medicine and manufacturing, check out our latest free-to-view feature: https://lnkd.in/edzX5Mfc

The power of Citeline Connect Marketplace: guide, explore, enroll, communicate. A marketplace that expands your recruitment horizons: https://ow.ly/uugN50Tpco8.

https://ow.ly/3NkL50UC7wL — With many people starting off the new year with resolutions to lose weight and last year's success of Novo Nordisk's Ozempic and Wegovy, it's no wonder that the pharma industry is paying attention to obesity drugs. Sara LaFever, MLIS, executive director of product services, shares with PharmaVoice her predictions on expected drug approvals in 2025. Read now: https://ow.ly/3NkL50UC7wL.